InsidersTradesSigma
Track the ST诺泰 stock price and the full insider trade history of the company, a listed issuer based in China. Shares are listed on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, ST诺泰 has recorded 7 public disclosures. Market capitalisation: €9bn. The latest transaction was disclosed on 14 July 2026 (Sale). Among the most active insiders: 刘婷. Every trade is accessible without an account.
7
Insider Decl.
n/a
Thresholds
€2,544
1 ops.
Buy Volume
€796,277
6 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 16,135 of 29,064 companies
48.9
score / 100
Value37
Quality61
FCF yld-7.7%
Earn yld3.7%
EV/EBITDA15.6x
ROE7.7%
Gross mgn63%
Net mgn17%
Debt/EBITDA3.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 14 July 2026
Declarations7 total
74,092 sharesA股XSHGSSE:173000007356399260
7 of 7 declarations
关于 ST诺泰
ST诺泰是一家在XSHG市场上市的医疗保健和制药公司。它专注于创新医药产品的开发和商业化。